The emergent role of metabolic phenotyping in dynamic patient stratification

Expert Opinion on Drug Metabolism and Toxicology

Volumn 10, Issue 7, 2014, Pages 915-919

  Lindon, John C ^a   Nicholson, Jeremy K ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Big data; Biomarkers; Cardiovascular; Diagnosis; Epidemiology; Mass spectrometry; Metabolomics; Metabonomics; NMR; Oncology; Phenotyping; Prognosis; Surgery

Indexed keywords

ANALYTIC METHOD; HUMAN; MASS SPECTROMETRY; METABOLISM; METAGENOMICS; MOLECULAR IMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATIENT STRATIFICATION; PERSONALIZED MEDICINE; PHENOTYPE; REVIEW; STRATIFICATION; METABOLOMICS; PROCEDURES; STATISTICAL MODEL;

HUMANS; INDIVIDUALIZED MEDICINE; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; METABOLOMICS; MODELS, STATISTICAL; PHENOTYPE;

EID: 84902523677     PISSN: 17425255     EISSN: 17447607     Source Type: Journal    
DOI: 10.1517/17425255.2014.922954     Document Type: Review

References (16)

1. Nicholson JK, Lindon JC, Holmes E. Metabonomics: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999;29:1181-9
2. Nicholson JK, Connelly J, Lindon JC, et al. Metabonomics: A platform for studying drug toxicity and gene function. Nat Rev Drug Discov 2002;1:153-61
3. Yatsunenko T, Rey FE, Manary MJ, et al. Human gut microbiome viewed across age and geography. Nature 2012;486:222-7
4. Lindon JC, Nicholson JK. Spectroscopic and statistical techniques for information recovery in metabonomics and metabolomics. Annu Rev Anal Chem 2008;1:45-69
5. Bouatra S, Aziat F, Mandal R, et al. The human urine metabolome. PLoS One 2013;8:e73076
6. Balog J, Sasi-Szabó L, Kinross J, et al. Intraoperative tissue identification using rapid evaporative ionization mass spectrometry. Sci Transl Med 2013;5:194ra93
7. National Institutes of Health Press Release. NIH announces new program in metabolomics. Available from: http://www.nih.gov/news/health/sep2012/od-19. htm [Last accessed 7 May 2014]
8. Imperial College London, MCR-NIHR National Phenome Centre. Available from: http://www1.imperial.ac.uk/phenomecentre/[Last accessed 7 May 2014]
9. NHS National Institute for Health Research. MRC/NIHR Phenome Centre. http://www.nihr.ac.uk/infrastructure/Pages/PhenomeCentre.aspx [Last accessed 7 May 2014]
10. Barba I, de León G, Mart?n E. Nuclear magnetic resonance-based metabolomics predicts exercise-induced ischemia in patients with suspected coronary artery disease. Magn Reson Med 2008;60:27-32
11. Shah AA, Craig DM, Sebek JK. Metabolic profiles predict adverse events after coronary artery bypass grafting. J Thorac Cardiovasc Surg 2012;143:873-8
12. Backshall A, Sharma R, Clarke SJ, et al. Pharmacometabonomic profiling as a predictor of toxicity in patients with inoperable colorectal cancer treated with capecitabine. Clin Cancer Res 2011;17:3019-28
13. Jiménez B, Mirnezami R, Kinross J, et al. 1H HR-MAS NMR spectroscopy of tumor-induced local metabolic field-effects enables colorectal cancer staging and prognostication. J Proteome Res 2013;12:959-68
14. Nicholson JK, Holmes E, Kinross JM, et al. Metabolic phenotyping in clinical and surgical environments. Nature 2012;491:384-92
15. Everett JR, Loo RL, Pullen FS. Pharmacometabonomics and personalized medicine. Ann Clin Biochem 2013;50:523-45
16. Yap IK, Brown IJ, Chan Q, et al. Metabolome-wide association study identifies multiple biomarkers that discriminate north and south Chinese populations at differing risks of cardiovascular disease: INTERMAP study. J Proteome Res 2010;9:6647-54